A New Hypromellose Capsule For Optimum Formulation Of Pharmaceutical Dosage Forms
Source: CapsugelĀ® | Lonza Pharma & Biotech
Hypromellose (HPMC) capsules were originally formulated with a secondary gelling agent. This agent can delay dissolution in some circumstances and lead to unwanted issues during product development.
In this article, we discuss the rationale for developing Capsugel’s Vcaps® Plus capsules without a gelling agent. We also describe how these capsules – now in use at many major pharmaceutical companies to encapsulate their existing over-the-counter [OTC] products and New Chemical Entities [NCEs] – can optimize product performance and improve product stability, as well as reduce development timelines.
access the White Paper!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.
Subscribe to Pharmaceutical Online
X
Subscribe to Pharmaceutical Online
This website uses cookies to ensure you get the best experience on our website. Learn more